Table of Contents
ISRN Hematology
Volume 2014 (2014), Article ID 363854, 5 pages
http://dx.doi.org/10.1155/2014/363854
Research Article

Phagocytized Neutrophil Fragments in the Bone Marrow: A Phenomenon Most Commonly Associated with Hodgkin Lymphoma

Department of Pathology and Laboratory Medicine, Nationwide Children’s Hospital, 700 Children's Drive, Columbus, OH 43205, USA

Received 19 December 2013; Accepted 28 January 2014; Published 18 March 2014

Academic Editors: H. Knecht and L. Visser

Copyright © 2014 Michael A. Arnold and Samir B. Kahwash. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Q. Huang, K. L. Chang, and L. M. Weiss, “Extranodal Rosai-Dorfman disease involving the bone marrow: a case report,” The American Journal of Surgical Pathology, vol. 30, no. 9, pp. 1189–1192, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Risma and M. B. Jordan, “Hemophagocytic lymphohistiocytosis: updates and evolving concepts,” Current Opinion in Pediatrics, vol. 24, no. 1, pp. 9–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. D. Gaiolla, M. A. C. Domingues, L. Niéro-Melo, and D. E. de Oliveira, “Serum levels of interleukins 6, 10, and 13 before and after treatment of classic Hodgkin lymphoma,” Archives of Pathology & Laboratory Medicine, vol. 135, no. 4, pp. 483–489, 2011. View at Google Scholar · View at Scopus
  4. M. Kowalska, J. Tajer, M. Chechlinska et al., “Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma,” Tumor Biology, vol. 33, no. 5, pp. 1733–1738, 2012. View at Publisher · View at Google Scholar
  5. K. Jones, F. Vari, C. Keane et al., “Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma,” Clinical Cancer Research, vol. 19, no. 3, pp. 731–742, 2013. View at Publisher · View at Google Scholar
  6. M. Sauer, A. Plütschow, R. D. Jachimowicz et al., “Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma,” American Journal of Hematology, vol. 88, no. 2, pp. 113–115, 2013. View at Publisher · View at Google Scholar
  7. R. Burkhardt, K. Zettl, and R. Bartl, “Significance of non-specific changes of the bone marrow tissues from the bioptic viewpoint,” Bibliotheca Haematologica, vol. 45, pp. 38–49, 1978. View at Google Scholar · View at Scopus
  8. J. H. Jandl, “Hodgkin's disease,” in Blood: Textbook of Hematology, J. H. Jandl, Ed., p. 1113, Little, Brown and Company, Boston, Mass, USA, 2nd edition, 1996. View at Google Scholar